Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01382524
Other study ID # 05-011427
Secondary ID
Status Completed
Phase N/A
First received June 24, 2011
Last updated June 12, 2013
Start date June 2011
Est. completion date September 2012

Study information

Verified date June 2013
Source 3M
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

Approximately 300 million short peripheral intravascular catheters (PIVs) were sold in the U.S. in 2009. These short (< 3 inches) peripherally inserted IV catheters are vital for providing patients with needed: 1) fluid, electrolyte, nutrient and blood product replacement, 2) medicines and 3) diagnostic solutions (dyes). However, these IV catheters have inherent risks or potential complications which may result from poor catheter securement or stabilization.

When a PIV catheter is not properly secured, motion and micro-motion within the vessel cause injury to the vein. This damage to the vein is a primary cause of phlebitis, a distressing complication of PIV therapy. Additional complications of inadequate stabilization of the PIV catheter are infiltration, leaking at the insertion site, pain, infection and dislodgement. According to Royer (2003), the most common reason for PIV catheter failure is infiltration and dislodgement. Infiltration is more dependent on keeping the extremity still, where phlebitis is dependent on injuries due to the chemical nature of the drugs and fluids infused or by the physical trauma to the endothelium from IV pushes.

The results of these complications are costly and can be serious if another vein cannot be immediately accessed or if the infiltrated infusate causes tissue necrosis. An unscheduled restart of another PIV catheter causes a delay in patient treatment, patient discomfort, patient dissatisfaction, safety concerns, nursing interruptions and additional costs. Actual costs associated with PIV catheter restarts include materials and nursing resources; yet intangibles such as, treatment for patient complications and patient dissatisfaction may be far more costly.

One way to reduce the incidence of PIV catheter-associated complications is to use technologies that help reduce catheter movement thereby improving catheter stabilization. In addition to stabilization platforms added to the peripheral IV catheter design, catheter stabilization devices and modified transparent film dressings also help to reduce catheter movement and could possibly eliminate the need for routine catheter site changes.

Therefore, the purpose of this study is to: 1) compare the number of PIV securement-related complications and PIV catheter restarts of one stabilization system to another stabilization system and 2) to determine which system provides a cost savings.


Description:

See brief summary


Recruitment information / eligibility

Status Completed
Enrollment 682
Est. completion date September 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- At least 18 years of age, unless an emancipated minor

- A patient who is admitted or going to be admitted to the hospital

- Requires peripheral IV therapy (catheter) for an anticipated 72 hours or longer.

- Has an insertion site in the forearm or hand free of deformities, phlebitis, infiltration, dermatitis, burns, lesions or tattoos

- Demonstrates cooperation with a catheter insertion and the securement protocol.

Exclusion Criteria:

- Is a current participant or a past participant in this study

- If the study PIV catheter will cross a joint or the catheter hub will hang off the fingers

- If the study PIV catheter site will be placed below an old infusion site

- If the study PIV site needs to be immobilized with a splint or other devices

- Has a documented or a known allergy or sensitivity to a medical adhesive product such as transparent film adhesive dressings, tapes or liquid skin protectants

- Requires the application of a gauze pad, a topical ointment or solution under the dressing in addition to the prep(s) required in the protocol

- Has or has had a previous IV catheter related phlebitis or infiltration during this hospitalization.

- Will have a vesicant administered through the study catheter, e.g. Dilantin

- Will require a power injection for a radiologic procedure during participation in this study

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of North Carolina Chapel Hill North Carolina
United States Wake Forest University Health Sciences Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
3M

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary PIV Catheter complication rates The primary endpoint for the study is the difference between the number and type of PIV-related complications (phlebitis, infiltration, dislodgement, leakage, local site infection and catheter line associated infection) between the two stabilization groups. Anticipated to be up to 4 days per participant No
Secondary Cost effectiveness The secondary endpoints are overall and specific complication rates, incidence of unscheduled restarts, incremental cost effective ratio for one stabilization system to another stabilization system. Anticipated to be up to 4 days per participant No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04054128 - Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients Phase 4
Recruiting NCT05729321 - Lock sOlutiOnS for Epicutaneo-caval Catheters in Neonates: a "LOOSEN" Pilot Study
Recruiting NCT05334225 - Assessing the Knowledge and Self-confidence of Healthcare Workers to Perform Transurethral Catheterization: A Multicenter Survey
Completed NCT06106659 - Comparison of Clinical Outcomes of Mini Midline Catheters With Different Placement Sites: a Randomized Controlled Trial N/A
Completed NCT03655106 - Ultrasound Guided Catheter Length Survivability N/A
Not yet recruiting NCT06014099 - Research on the Application of Blood Collection Through Midline Catheters of Different Lengths N/A
Completed NCT03693755 - Dislocation Rates of Femoral Catheter Placed Sonographically Either In-plane or Out-of-plane N/A
Not yet recruiting NCT06019897 - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Not yet recruiting NCT06149533 - Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients Phase 3
Completed NCT01465594 - Study Comparing Urinary Diversion (Transurethral/Suprapubic) After Radical Prostatectomy N/A
Recruiting NCT06001827 - SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study N/A
Completed NCT04569474 - Peripheral IV Dressing and Phlebitis in Patients From Amazon N/A
Completed NCT05814887 - Reduction of Mechanical IV Complication Using a New Medical Device N/A
Recruiting NCT05741866 - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) N/A
Completed NCT06312215 - Effect Of Open And Closed System Peripheral Catheters Used In Pediatric Services N/A
Recruiting NCT04359056 - Clinical Pharmacy for Patients With a PICC Line N/A
Not yet recruiting NCT05869877 - The PIV5Rights Safety and Quality Bundle N/A
Recruiting NCT04548713 - CLiCK in the Critical Care Unit N/A
Completed NCT04285775 - A Novel Device for Surveillance of Vascular Access Sites for Bleeding
Completed NCT05446987 - Position Change and Back Massage Versus Early Ambulation on Post Transfemoral Coronary Angiography Complications N/A